Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
about
Current and future treatment options in SIADHVasopressin: behavioral roles of an "original" neuropeptideReview of Tolvaptan's Pharmacokinetic and Pharmacodynamic Properties and Drug InteractionsRole of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectivesThe treatment of hyponatraemia using vasopressin antagonists.Management of hyponatraemia in older people: old threats and new opportunitiesDevelopment and therapeutic indications of orally-active non-peptide vasopressin receptor antagonists.Prostate adenocarcinoma producing syndrome of inappropriate secretion of antidiuretic hormone.Vasopressin receptor antagonists and their role in clinical medicine.Hyponatraemia for the clinical endocrinologist.Tolvaptan: a selective vasopressin type 2 receptor antagonist in congestive heart failure.Vasopressin antagonists: role in the management of hyponatremia.Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion.Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.Nutrition-focused evaluation and management of dysnatremias.Embolization of metastatic neuroendocrine tumor resulting in clinical manifestations of syndrome of inappropriate secretion of antidiuretic hormone.Hyponatremia and the use of vasopressin receptor antagonists in critically ill patients.Tolvaptan for the treatment of hyponatremia secondary to the syndrome of inappropriate antidiuretic hormone secretion.Significance of hypo- and hypernatremia in chronic kidney disease.Dynamic regulation and dysregulation of the water channel aquaporin-2: a common cause of and promising therapeutic target for water balance disorders.Hyponatremia as an independent prognostic factor in patients with terminal cancer.Is Exaggerated Release of Arginine Vasopressin an Endocrine Disorder? Pathophysiology and Treatment.Targeted overexpression of endothelin-1 in astrocytes leads to more severe cytotoxic brain edema and higher mortality.
P2860
Q24652519-6587E235-292D-4034-AB28-7B996AD5E0CCQ24656284-5B7447B6-A8E3-4248-A39E-47741820CAC6Q26995169-DD42055A-55A6-436F-9219-2B976B826DFFQ28072768-2575A8CD-1421-4D96-ADB5-C8F9C8BCD990Q33906415-0E9AA4DC-61C4-4083-8A61-9316025DA373Q33949221-4814147B-6092-48C2-8C4C-DA68DE8E2E9AQ34232014-8687CCC3-46EE-482C-A144-45138EFE30CDQ34421581-F1CEABCC-F9BB-462D-8E5D-ECFCD6DD50A5Q35856033-41B81726-0562-4343-ABB9-F7FC48A79F32Q36266368-FF2888E5-5E91-47F5-8F58-FB38677F6C5FQ36458380-F1524E5B-9B6A-4BD3-94F5-DD1B63C08429Q36534664-0FF400BD-410D-470A-AAC6-F38A513B4A06Q36614000-A7281807-3BD6-492E-AA90-E28870CEC6FBQ36684711-8E9DD106-216D-4C4C-913F-F74E0875D604Q37129218-5660F57A-1B56-443C-B958-A7605A12975CQ37343734-0F666B4E-1FAC-4BBF-A8BA-3893A2C3BB76Q37875586-2709C9B5-3458-4440-8102-45BA2722EFA3Q37959051-302E9622-35CB-41CB-BB13-9DD3BC52A53EQ37989443-B9ADDDA1-6C8C-4D91-AC1C-C61C3AEFCA3DQ38152961-A40CE052-DD86-4E7E-8EA1-060ED0C3B478Q39092737-4E5A6994-782A-4FDC-A5A0-1C9C024D6C2EQ47125977-80598AE6-1ABD-4B45-9302-E2EAB840B004Q48475906-4AEA9FAE-60D0-4C49-9E75-225DC4E7DE0B
P2860
Acute aquaresis by the nonpeptide arginine vasopressin (AVP) antagonist OPC-31260 improves hyponatremia in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH)
description
1997 nî lūn-bûn
@nan
1997 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@ast
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@en
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@nl
type
label
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@ast
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@en
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@nl
prefLabel
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@ast
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@en
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@nl
P2093
P3181
P1476
Acute aquaresis by the nonpept ...... f antidiuretic hormone (SIADH)
@en
P2093
S Ishikawa
P304
P3181
P356
10.1210/JC.82.4.1054
10.1210/JCEM.82.4.3900
P407
P577
1997-04-01T00:00:00Z